BGLC vs TPR · rev $99.0K vs P/E 46, rev $8.00B
BioNexus Gene Lab Corp Common stock (BGLC) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
BGLC currently screens at market cap $6.1M. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the BGLC and TPR stock pages for the full models.
Not investment advice.